Number of the records: 1  

Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and bevacizumab

  1. SYS0052078
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20101001141630.2
    100
      
    $a 20101001a2006 m y0sloy0103 ba
    101
    0-
    $a eng
    102
      
    $a SE
    200
    1-
    $a Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and bevacizumab $f J. Drimal ... [et al.]
    303
      
    $a Popis urobený z citácie
    463
    -1
    $1 200 1 $a Neuro endocrinology letters $v Vol. 27, suppl. 2 (2006), s. 176-179
    701
    -1
    $3 sllk_un_auth*p0044574 $a Dřímal $b Ján $c sr. $4 070 $p Ústav experimentálnej farmakológie SAV, Bratislava
    701
    -1
    $3 sllk_un_auth*p0043930 $a Zúrová-Nedelcevová $b Jana $4 070 $p Ústav experimentálnej farmakológie SAV, Bratislava
    701
    -1
    $3 sllk_un_auth*p0054445 $a Knezl $b Vladimír $4 070 $p Ústav experimentálnej farmakológie SAV, Bratislava
    701
    -1
    $3 sllk_un_auth*p0057080 $a Sotníková $b Ružena $4 070 $p Ústav experimentálnej farmakológie SAV, Bratislava
    701
    -1
    $3 sllk_un_auth*p0053791 $a Navarová $b Jana $4 070 $p Ústav experimentálnej farmakológie SAV, Bratislava
    801
    -0
    $a SK $b BA006 $c 20101001 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.